ILTS-iLDLT-LTSI 2023 Consensus Conference: Prediction and Management of Small for Size Syndrome in LDLT (Videos)

ILTS-iLDLT-LTSI 2023 Consensus Conference: Prediction and Management of Small for Size Syndrome in LDLT are organized by International Liver Transplantation Society (ILTS) held on Jan 27, 2023, at ITC Grand Chola, Chennai, Tamil Nadu, India.

In this Consensus Conference, we will discuss:
• The approach to patients with an SFSG
• The incidence, definitions, clinical factors, and biomarkers of SFSS.
• Donor and recipient factors that increase the risk of SFSS and how to optimize these factors to reduce its incidence.
• Perioperative considerations in the management of a patient with SFSG
• Treatment and management of established SFSS.

Learning Objectives:
• Understand the gap in current practice by reviewing and summarizing published evidence on SFSS in LDLT.
• Define criteria and prediction models for SFSS in patients undergoing LDLT with an SFSG.
• Identification and timely intervention in patients with SFSG to reduce the risk of SFSS.
• Provide recommendations and guidelines for the optimal multidisciplinary management of patients undergoing established SFSS.

Expected Educational Outcomes:
The participants will be able to review and discuss research regarding SFSS, including selection criteria/indications, prognostic models, surveillance strategies, novel therapies and management. The participants will benefit from a clear elucidation of the current knowledge of portal hemodynamics and its practical application for SFSG in LDLT to prevent and manage SFSS. The participants will gain insight into innovations that lead to improvements in the field of LDLT.

Contents:

Day 1 – 01 Introduction
Day 1 – 02 Methodology
Day 1 – 03 WG1 Diagnostic criteria – Toru Ikegami
Day 1 – 04 Topic 1a – Presentation & voting
Day 1 – 05 Topic 1b – Presentation & voting
Day 1 – 06 Topic 1c – Presentation & voting
Day 1 – 07 Working group 1
Day 1 – 08 – WG2 Preventing SFSS – Roberto Troisi
Day 1 – 09 Topic 2a – Donor selection
Day 1 – 10 Topic 2b – Recipient selection
Day 1 – 11 Topic 2c
Day 1 – 12 WG3 Anesthetic considerations – James Findlay
Day 1 – 17 Topic 4a – Medical
Day 1 – 18 Topic 4b – Interventional
Day 1 – 19 Topic 4c – Retransplantation
Day 2 – 01 ACLF Definitions – Sarin
Day 2 – 02 – Hiroto Egawa – LT for ACLF
Day 2 – 03 – ERAS in LT West vs East
Day 2 – 04 – Machine perfusion
Day 2 – 05 – Coagulation in LT – Klaus Gorlinger
Day 2 – 06 – Cardiac monitoring in LT
Day 2 – 07 – Liver Kidney donation – Pomfret
Day 2 – 08 – LT for HCC PVTT Debate
Day 2 – 09 – Altruistic donation – Cattral
Day 2 – 10 – NAT for HCC – Chen
Day 2 – 11 – LT for hyperoxaluria
Day 2 – 12 – LT for cholangiocarcinoma – Mark Ghobrial
Day 2 – 13 – LT in obese patients
Day 2 – 15 – Renal protection in LT – Marina Berenguer

Info: In-person only topics and sessions are not recorded. Please see above content.